Home/Frezent Biological Solutions/Natasha Shtraizent, PhD

NS

Natasha Shtraizent, PhD

Chief Executive Officer, Co-founder

Frezent Biological Solutions

Therapeutic Areas

Frezent Biological Solutions Pipeline

Drug	Indication	Phase
Undisclosed Antibody/ADC Program	Head and Neck Cancer	Pre-clinical
Platform Pipeline	Osteosarcoma, Pancreatic Cancer	Research/Discovery

Leadership Team at Frezent Biological Solutions

Lina Freage-Kahn, PhD

Chief Scientific Officer, Co-founder

View full Frezent Biological Solutions profile